- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Indrayani Biotech has released a corrected PDF version of its Q1 financial results for the current fiscal year. The company clarified that while the XBRL format of the previously filed results was accurate, the PDF version contained editing errors. This ensures all stakeholders have access to precise financial information. For the quarter, consolidated net sales were 29.10 Cr with a net profit of 0.16 Cr. Standalone net sales were 6.69 Cr, resulting in a net profit of 0.13 Cr. This correction provides investors with accurate data for their review.